Search Thermo Fisher Scientific
Additional Information: The immunizing peptide represents part of the cytoplasmic domain. The antibody is not expected to cross-react with other glycine receptor alpha proteins.
This antibody is tested in Peptide ELISA: antibody detection limit dilution 1:128,000.
GLRA1 is a subunit of a pentameric inhibitory glycine receptor, which mediates postsynaptic inhibition in the central nervous system. Defects in GLRA1 are a cause of startle disease (STHE), also known as hereditary hyperekplexia or congenital stiff-person syndrome. Multiple transcript variants encoding different isoforms have been found for GLRA1. Glycine receptors (GlyR) that include GLRA1 are members of the cys-loop family of ligand-gated ion channels, responsible for mediating the inhibitory effects of glycine. GLRA1 are widely distributed throughout the CNS, particularly within the hippocampus, spinal cord and brain stem. Diseases associated with GLRA1 include Hyperekplexia, Hereditary 1 and Hyperekplexia.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: GLRA; Glra2; glycine receptor; Glycine receptor 48 kDa subunit; Glycine receptor strychnine-binding subunit; Glycine receptor subunit alpha-1; glycine receptor, alpha 1 subunit; gra1
基因别名: GLRA1; Glyr; GLYRA1; HKPX1; nmf11; oscillator; ot; spasmodic; spd; STHE
UniProt ID: (Human) P23415, (Mouse) Q64018, (Rat) P07727
Entrez Gene ID: (Human) 2741, (Mouse) 14654, (Rat) 25674